134 related articles for article (PubMed ID: 18218995)
1. CaSm (LSm-1) overexpression in lung cancer and mesothelioma is required for transformed phenotypes.
Watson PM; Miller SW; Fraig M; Cole DJ; Watson DK; Boylan AM
Am J Respir Cell Mol Biol; 2008 Jun; 38(6):671-8. PubMed ID: 18218995
[TBL] [Abstract][Full Text] [Related]
2. CaSm-mediated cellular transformation is associated with altered gene expression and messenger RNA stability.
Fraser MM; Watson PM; Fraig MM; Kelley JR; Nelson PS; Boylan AM; Cole DJ; Watson DK
Cancer Res; 2005 Jul; 65(14):6228-36. PubMed ID: 16024624
[TBL] [Abstract][Full Text] [Related]
3. CaSm: an Sm-like protein that contributes to the transformed state in cancer cells.
Schweinfest CW; Graber MW; Chapman JM; Papas TS; Baron PL; Watson DK
Cancer Res; 1997 Jul; 57(14):2961-5. PubMed ID: 9230209
[TBL] [Abstract][Full Text] [Related]
4. Establishing a murine pancreatic cancer CaSm model: up-regulation of CaSm is required for the transformed phenotype of murine pancreatic adenocarcinoma.
Yan Y; Rubinchik S; Watson PM; Kelley JR; Fraser MM; Wood AL; Dong JY; Gillanders WE; Boylan AM; Watson DK; Cole DJ
Mol Ther; 2005 Mar; 11(3):363-72. PubMed ID: 15727932
[TBL] [Abstract][Full Text] [Related]
5. Restoration of Wnt-7a expression reverses non-small cell lung cancer cellular transformation through frizzled-9-mediated growth inhibition and promotion of cell differentiation.
Winn RA; Marek L; Han SY; Rodriguez K; Rodriguez N; Hammond M; Van Scoyk M; Acosta H; Mirus J; Barry N; Bren-Mattison Y; Van Raay TJ; Nemenoff RA; Heasley LE
J Biol Chem; 2005 May; 280(20):19625-34. PubMed ID: 15705594
[TBL] [Abstract][Full Text] [Related]
6. CaSm antisense gene therapy: a novel approach for the treatment of pancreatic cancer.
Kelley JR; Fraser MM; Hubbard JM; Watson DK; Cole DJ
Anticancer Res; 2003; 23(3A):2007-13. PubMed ID: 12894573
[TBL] [Abstract][Full Text] [Related]
7. Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer.
Modi S; Kubo A; Oie H; Coxon AB; Rehmatulla A; Kaye FJ
Oncogene; 2000 Sep; 19(40):4632-9. PubMed ID: 11030152
[TBL] [Abstract][Full Text] [Related]
8. The cancer-associated Sm-like oncogene: a novel target for the gene therapy of pancreatic cancer.
Kelley JR; Brown JM; Frasier MM; Baron PL; Schweinfest CW; Vournakis JN; Watson DK; Cole DJ
Surgery; 2000 Aug; 128(2):353-60. PubMed ID: 10923016
[TBL] [Abstract][Full Text] [Related]
9. The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have c-src upregulation.
Kanou T; Oneyama C; Kawahara K; Okimura A; Ohta M; Ikeda N; Shintani Y; Okumura M; Okada M
Mol Cancer Res; 2011 Jan; 9(1):103-14. PubMed ID: 21156787
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of MMP-2 by HMGA1 promotes transformation in undifferentiated, large-cell lung cancer.
Hillion J; Wood LJ; Mukherjee M; Bhattacharya R; Di Cello F; Kowalski J; Elbahloul O; Segal J; Poirier J; Rudin CM; Dhara S; Belton A; Joseph B; Zucker S; Resar LM
Mol Cancer Res; 2009 Nov; 7(11):1803-12. PubMed ID: 19903768
[TBL] [Abstract][Full Text] [Related]
11. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.
Cohen AJ; Bunn PA; Franklin W; Magill-Solc C; Hartmann C; Helfrich B; Gilman L; Folkvord J; Helm K; Miller YE
Cancer Res; 1996 Feb; 56(4):831-9. PubMed ID: 8631021
[TBL] [Abstract][Full Text] [Related]
12. Bystander effect contributes to the antitumor efficacy of CaSm antisense gene therapy in a preclinical model of advanced pancreatic cancer.
Yan Y; Rubinchik S; Wood AL; Gillanders WE; Dong JY; Watson DK; Cole DJ
Mol Ther; 2006 Feb; 13(2):357-65. PubMed ID: 16226492
[TBL] [Abstract][Full Text] [Related]
13. HOX transcription factors are potential targets and markers in malignant mesothelioma.
Morgan R; Simpson G; Gray S; Gillett C; Tabi Z; Spicer J; Harrington KJ; Pandha HS
BMC Cancer; 2016 Feb; 16():85. PubMed ID: 26867567
[TBL] [Abstract][Full Text] [Related]
14. Pin1 expression contributes to lung cancer: Prognosis and carcinogenesis.
Tan X; Zhou F; Wan J; Hang J; Chen Z; Li B; Zhang C; Shao K; Jiang P; Shi S; Feng X; Lv N; Wang Z; Ling Y; Zhao X; Ding D; Sun J; Xiong M; He J
Cancer Biol Ther; 2010 Jan; 9(2):111-9. PubMed ID: 20009523
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation.
Sun C; Liu Z; Li S; Yang C; Xue R; Xi Y; Wang L; Wang S; He Q; Huang J; Xie S; Jiang W; Li D
Oncotarget; 2015 Sep; 6(28):25533-74. PubMed ID: 26325180
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Pharmacogenomic Profiling of Malignant Pleural Mesothelioma Identifies a Subgroup Sensitive to FGFR Inhibition.
Quispel-Janssen JM; Badhai J; Schunselaar L; Price S; Brammeld J; Iorio F; Kolluri K; Garnett M; Berns A; Baas P; McDermott U; Neefjes J; Alifrangis C
Clin Cancer Res; 2018 Jan; 24(1):84-94. PubMed ID: 29061644
[No Abstract] [Full Text] [Related]
17. Functional Analysis of the Adrenomedullin Pathway in Malignant Pleural Mesothelioma.
Greillier L; Tounsi A; Berenguer-Daizé C; Dussault N; Delfino C; Benyahia Z; Cayol M; Mabrouk K; Garcia S; Martin PM; Barlesi F; Ouafik L
J Thorac Oncol; 2016 Jan; 11(1):94-107. PubMed ID: 26762744
[TBL] [Abstract][Full Text] [Related]
18. RNA-binding protein KHSRP promotes tumor growth and metastasis in non-small cell lung cancer.
Yan M; Sun L; Li J; Yu H; Lin H; Yu T; Zhao F; Zhu M; Liu L; Geng Q; Kong H; Pan H; Yao M
J Exp Clin Cancer Res; 2019 Nov; 38(1):478. PubMed ID: 31775888
[TBL] [Abstract][Full Text] [Related]
19. Wnt pathway activation in mesothelioma: evidence of Dishevelled overexpression and transcriptional activity of beta-catenin.
Uematsu K; Kanazawa S; You L; He B; Xu Z; Li K; Peterlin BM; McCormick F; Jablons DM
Cancer Res; 2003 Aug; 63(15):4547-51. PubMed ID: 12907630
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-37 suppresses tumor growth through inhibition of angiogenesis in non-small cell lung cancer.
Ge G; Wang A; Yang J; Chen Y; Yang J; Li Y; Xue Y
J Exp Clin Cancer Res; 2016 Jan; 35():13. PubMed ID: 26791086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]